Two FDA Decisions for Regeneron’s Eylea HD Delayed Into Q4By Leonardo Arias / 21/08/2025 The delays, first revealed in Regeron’s Q2 report, were chalked up to manufacturing issues at Novo Nordisk-owned plants.
